Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
about
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progressionTransforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cellsRole of RUNX2 in Breast CarcinogenesisThe RUNX genes: gain or loss of function in cancerThe Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasionRunx expression is mitogenic and mutually linked to Wnt activity in blastula-stage sea urchin embryosMPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.Prostate cancer regulatory networksThe Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region.Actin microfilament mediates osteoblast Cbfa1 responsiveness to BMP2 under simulated microgravityRegulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cellsβ-Catenin independent cross-control between the estradiol and Wnt pathways in osteoblastsThe cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct bindingThe HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β.Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formationIntegrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cellsRunx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cellsDefining the roles of inflammatory and anabolic cytokines in cartilage metabolism.Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis.Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp.RUNX2 in mammary gland development and breast cancer.Current understanding on the molecular basis of chondrogenesis.Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.A Molecular View of Pathological Microcalcification in Breast Cancer.MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3.The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor.Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells.Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis.Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-caseinThe pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
P2860
Q26800112-669E6828-DC6A-4798-B69C-AC279E6303A9Q26996742-6175E3B8-63C2-4256-B35F-E195319FC9CAQ28084968-1FC9A7AD-DCFE-4B20-BC9B-4EE095B2E385Q28247901-E05E7E0B-273F-401D-9C33-890E410EA01DQ30447945-22E92B63-5CD5-4995-908F-328861B09D54Q33385660-99532A8B-0C58-4FB5-96C5-95D52D7E639EQ33708991-C08FB42E-BE01-425D-855F-BF5E2D4AA6CCQ33960568-BFBC6E74-DA37-44C1-BE29-86323E2214F5Q34000528-6C6B7D67-5D7D-4E48-8EA0-C596A8534D75Q34521966-858D3E7A-A663-4A12-82FB-E52A546C1E6CQ34722945-CB5EA6AC-FB83-474B-B36D-C253D679973AQ34868170-42C7C4CF-C339-4D53-AB61-5F881C880924Q34981232-BE9DF639-E24E-4940-9DBC-6899672949DCQ35065263-F3D3C6A4-05EF-4E68-BEEB-5A40E678A425Q35653009-0E0851B7-DC02-4E06-A1AC-B0E7F1C211BEQ35839788-C9D5C3F0-67B2-4C8D-A19A-C0921FFA8217Q35987559-0583C113-5FD6-4575-B20E-EA2E218A1F43Q36402883-22370308-1941-4C3E-AADB-D7722A20A90BQ36413997-A001EF5B-396C-4AD8-949A-72671F40B770Q36731376-5F142B24-0EDD-4B32-BF6A-7CF0FAAA2E10Q36937029-23959AF7-EB8C-40C0-9B6A-503CB5F963AFQ37000350-DFC1C783-5ED5-4978-A3CB-63DB0616C68DQ37331102-2A81C1AB-E9BB-40CC-8CBF-8BFC7F9E0E17Q37609032-352BA7FC-4CA7-4B99-9D31-ED2B3D60F278Q37648701-59D86972-751E-4D2C-9EB1-A25FF448D2E6Q38061373-742E45BA-0559-4E71-B90D-9670AA0BC930Q38188554-2DD29BD7-EB2C-45BE-9BC7-7B0F2132FB49Q38340672-867D1B3E-96EE-47EE-8558-48682C2FFC91Q38697305-7DD00087-30F6-4E15-869C-291C58B3E6EAQ38712590-65E7E1F3-D156-4A03-A530-B121B3BAAEC5Q38744455-B0DFB2EC-B127-4504-BA3B-9FE4A9776DEDQ39384202-7C084077-33AC-4C15-AE11-E82DA06DA99DQ39443785-28B6E49E-3E5A-4899-8656-9F93ECA79662Q39635816-453B0070-B0C0-43D4-AAE5-7245BB7B7840Q40594788-3B9CB18F-08A5-4CFF-8C89-5144F4EF8079Q41964841-B33D8F40-3CC5-43CA-B7E2-B6409A6E5B05Q42709917-413DDAF0-0B66-46A6-B731-B3B35DAD8BEBQ43244499-6C814F8C-1697-4178-8C5D-EF0CF9AC33C4Q44871921-9463D201-C6FB-4546-A9BD-C03088B487B6Q46303094-C18087CC-B78A-4C8C-AEB4-A65D7B51240F
P2860
Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Smad3 interacts with JunB and ...... in human breast cancer cells.
@en
type
label
Smad3 interacts with JunB and ...... in human breast cancer cells.
@en
prefLabel
Smad3 interacts with JunB and ...... in human breast cancer cells.
@en
P2093
P2860
P356
P1476
Smad3 interacts with JunB and ...... in human breast cancer cells.
@en
P2093
Nagarajan Selvamurugan
Nicola C Partridge
Sukyee Kwok
P2860
P304
27764-27773
P356
10.1074/JBC.M312870200
P407
P577
2004-04-14T00:00:00Z